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EDITORIAL
Many cell types are Shiga toxin targets
Shiga toxin (Stx)-producing Escherichia coli (STEC) cell damage in Stx HUS has now been derived from
are the most frequent causes of hemolytic uremic syn- many studies. For example, Hughes, Stricklett and Ko-
drome (HUS). Shiga toxin-associated HUS (Stx HUS) han demonstrated that Stx directly injures human proxi-
occurs in 5 to 15% of infants and children with STEC mal tubule cells in vitro [8]. Cultured distal renal tubule
gastroenteritis. After ingestion, STEC colonize the intes- cells also express Gb3 and undergo apoptosis after expo-
tine and produce Stx1 and Stx2 that translocate across sure to Stx [9]. Furthermore, Uchida et al demonstrated
the intestinal epithelium and subsequently injure sensi- the presence of Stx1 and Stx2 in a portion of distal tubu-
tive endothelial cell beds [1]. Stx are comprised of an A lar epithelial cells of a patient with Stx HUS [10]. Gb3 is
subunit with N-glycanase activity, and five smaller B expressed on cultured human mesangial cells. Mesangial
subunits capable of binding to the functional receptor cells are also injured in patients with Stx HUS and dam-
globotriaosylceramide (Gb3) [2]. Despite having many age ranges from mild cellular edema to severe mesangio-
common physical and biochemical properties, Stx1 and lysis. Stx1 inhibits protein synthesis (potentiated by pre-
Stx2 cross the intestinal epithelial cell barrier by different incubation of the cells with IL-1 or TNF-a), activates
pathways [3]. Stx induces an increase in chemokine syn- chemokine genes and results in lethal toxic injury [11].
thesis from intestinal epithelial cells that augment host In this issue of Kidney International Hughes et al stud-
mucosal inflammatory responses with release of interleu- ied the effects of Stx1 on human glomerular epithelial
kin (IL)-8, t(TNF) and IL-1 [4]. It is not known whether cells (human GEC) and have added to our growing un-
STEC release Stx in single or multiple waves. Treatment derstanding of Stx-induced renal damage. They showed
of the gastroenteritis probably increases the chances that that human GEC express Gb3, are susceptible to the
STEC gastroenteritis will result in Stx HUS. toxic effects of Stx1, and that the effects of Stx1 are
Shiga toxin-induced endothelial cell damage appears amplified by exposure to pro-inflammatory IL-1, TNF,
to be the central event in the pathogenesis of renal dys- LPS and butyrate [12]. This suggests that human GEC
function and injury in Stx HUS, as evidenced by endothelial may be early targets of Stx and that they also experience
cell swelling, detachment, and abnormalities in procoag- inhibition of protein synthesis, disruption of podocyte
ulant and anticoagulant endothelial functions. Cytokines adhesion, and release of pro-inflammatory cytokines,
and lipopolysaccharide (LPS) enhance Stx sensitivity in procoagulants, vasoactive factors or extracellular matrix
cultured human umbilical vascular endothelial cells degrading enzymes.
(HUVEC) and may thereby contribute to the develop- All of these studies indicate that Stx has toxic effects
ment of HUS [5]. Stx administered to rats stimulates beyond renal arteriolar and glomerular endothelial cells.
production of thromboxane A2, increases endothelial cell Targets of Stx-induced cell injury include renal, aortic,
retraction, results in the formation of gaps in glomerular and brain endothelial cells, mesangial cells, proximal and
endothelial cell monolayers, and decreases the adhesion distal renal tubular epithelial cells, monocytes and cells
of glomerular endothelial cells to fibronectin and laminin derived from the monocytic cell line, astrocytoma cells,
[6]. Activation of human endothelium by TNF or IL-1 lung epithelial cells and glomerular epithelial cells. Stx
leads to an increase in Gb3 synthesis, an increase in the also has direct effects on polymorphonuclear cells [13],
expressed functional Gb3 receptor and increased cell and there is evidence that erythrocytes and platelets have
death after exposure to Stx [7]. receptors for Stx [14]. After intestinal absorption, Stx
There is increasing evidence that endothelial cells are must pass through the liver before reaching the systemic
not the only targets for Stx in the kidney, and that several circulation. It is intriguing that liver dysfunction is not
renal cell types have receptors for Stx and are damaged a major component of Stx HUS and that Gb3 receptors
by this toxin. Renal tubular injury in Stx HUS should have not, to our knowledge, been demonstrated in Kupf-
no longer be considered secondary to only glomerular fer cells, endothelial cells or hepatocytes.
and arteriolar injury. Evidence for primary renal tubular The findings by Hughes et al on human GEC are
timely because of increasing interest in the role of GEC
in the pathogenesis of acute and chronic renal injuryKey words: hemolytic uremic syndrome, infection, nephrotoxicity, re-
nal injury. [15]. Patients who survive severe episodes of Stx HUS
with prolonged anuria are at increased risk for chronicÓ 2000 by the International Society of Nephrology
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